27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Anebulo Pharmaceuticals (NASDAQ:ANEB) reported its Q3 earnings results on Thursday, May 11, 2023 at 08:00 AM.
Here's what investors need to know about the announcement.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Earnings
Anebulo Pharmaceuticals beat estimated earnings by 31.25%, reporting an EPS of $-0.11 versus an estimate of $-0.16.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04 which was followed by a 3.83% increase in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Anebulo Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.